Cuu Long Pharmaceutical JSC (HOSE:DCL)

Market Cap	3.06T +71.5%
Revenue (ttm)	1.32T +1.1%
Net Income	19.52B -63.6%
EPS	267.00 -62.2%
Shares Out	73.04M
PE Ratio	156.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	960,595
Average Volume	654,558
Open	43,300
Previous Close	45,000
Day's Range	41,850 - 45,850
52-Week Range	19,000 - 62,800
Beta	0.63
RSI	22.34
Earnings Date	Apr 24, 2026

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, nervous system, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, phar...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 880
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2025, HOSE:DCL's revenue was 1.32 trillion, an increase of 1.13% compared to the previous year's 1.31 trillion. Earnings were 19.52 billion, a decrease of -62.16%.